Aligos therapeutics announces award of an $8.5 million niaid contract to advance development of best-in-class pan-coronavirus protease inhibitor, alg-097558

- niaid contract will support conducting nonclinical and clinical studies to advance alg-097558 into future phase 2/3 studies

ALGS Ratings Summary

ALGS Quant Ranking